DHL study predicts direct distribution channels to the end consumer for the pharmaceutical and medical device manufacturers- DHL research identifies five crucial implications and action opportunities for supply chain management in 2020 and beyond
- Comprehensive report highlights trends for pharmaceutical and medical device manufacturers
Bonn, 11 June, 2013: DHL, the world’s leading logistics provider, has released an outlook on key logistics trends in the Life Sciences sector for 2020 and beyond. Compiled in a white paper by DHL Customer Solutions & Innovation based on current developments and megatrends, the report derives five key logistics implications and action needs for the industry: direct distribution to end consumers; increasing differentiation of supply chains; deepening access of emerging markets to tier-2 and tier-3 cities; rising importance of supply chain visibility to enable demand driven supply chains and process outsourcing; and finally the need for companies to keep their supply chain flexible to adapt to requirements of innovative products.
Import / Export
Travel / Tourism
Trade / Finance
Business / Mgmt
Govt / Military